CoChat

Reexamining assumptions about miRNA-guided gene silencing

Open access
Kilikevicius, Audrius, Meister, Gunter, Corey, David R · 2022 · Nucleic Acids Research

The DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.

Abstract

MicroRNAs (miRNAs) are short endogenously expressed RNAs that have the potential to regulate the expression of any RNA. This potential has led to the publication of several thousand papers each year connecting miRNAs to many different genes and human diseases. By contrast, relatively few papers appear that investigate the molecular mechanism used by miRNAs. There is a disconnect between rigorous understanding of mechanism and the extraordinary diversity of reported roles for miRNAs. Consequences of this disconnect include confusion about the assumptions underlying the basic science of human miRNAs and slow development of therapeutics that target miRNAs. Here, we present an overview of investigations into miRNAs and their impact on gene expression. Progress in our understanding of miRNAs would be aided by a greater focus on the mechanism of miRNAs and a higher burden of evidence on researchers who seek to link expression of a particular miRNA to a biological phenotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkab1256

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Biogenesis of miRNAs. (A) A miRNA is transcribed into pri-miRNA by Pol II. (B) Drosha/DCGR8 microprocessor complex cleaves the pri-miRNA to pre-miRNA, which enters the cytoplasm. (C) The mature duplex miRNA is generated by Dicer.
Figure 1. Biogenesis of miRNAs. (A) A miRNA is transcribed into pri-miRNA by Pol II. (B) Drosha/DCGR8 microprocessor complex cleaves the pri-miRNA to pre-miRNA, which enters the cytoplasm. (C) The mature duplex miRNA is generated by Dicer.CC BY-NC · PubMed Central
Figure 2. Interactions between AGO protein, an miRNA guide strand, and an RNA target. AGO proteins are composed of four domains: The N-terminal domain supports miRNA loading, the PAZ domain anchors the 3′ end while the MID domain binds the 5′ end of the miRNA. (A) Argonaute loaded miRNA seed region and other regions. (B) PIWI is the protein domain responsible for cleaving RNA substrates by AGO2 when there is full complementarity. (C) Centrally mismatched bases will block cleavage while permitting binding of a miRNA to a target RNA. PAZ – PIWI-Argonaute-Zwille, N – N-terminal (amino-terminal), PIWI – P-element-induced whimpy testes and MID – middle domains.
Figure 2. Interactions between AGO protein, an miRNA guide strand, and an RNA target. AGO proteins are composed of four domains: The N-terminal domain supports miRNA loading, the PAZ domain anchors the 3′ end while the MID domain binds the 5′ end of the miRNA. (A) Argonaute loaded miRNA seed region and other regions. (B) PIWI is the protein domain responsible for cleaving RNA substrates by AGO2 when there is full complementarity. (C) Centrally mismatched bases will block cleavage while permitting binding of a miRNA to a target RNA. PAZ – PIWI-Argonaute-Zwille, N – N-terminal (amino-terminal), PIWI – P-element-induced whimpy testes and MID – middle domains.CC BY-NC · PubMed Central
Figure 3. miRNA families. (A) Six miRNA families account for ∼50% of top 100 miRNAs loaded on AGO2 in HCT116 cells (60). (B) miR-96 is the only member of its family while Let-7 has several family members expressed. (C) Sequence variation among Let-7–5p/98–5p family members.
Figure 3. miRNA families. (A) Six miRNA families account for ∼50% of top 100 miRNAs loaded on AGO2 in HCT116 cells (60). (B) miR-96 is the only member of its family while Let-7 has several family members expressed. (C) Sequence variation among Let-7–5p/98–5p family members.CC BY-NC · PubMed Central
Figure 4. An example of the impact of cooperative binding on repression of gene expression by duplex RNAs. In this example an anti-CAG repeat duplex RNA is introduced into patient-derived Huntington's disease cells. (A) The wild-type huntingtin (HTT) allele has 17 repeats, while the mutant allele has 69 repeats. 1–2 anti-CAG small RNAs can bind to the wild-type allele while as many as nine anti-CAG RNAs can bind to the mutant allele. (B) Allele selective inhibition by a small RNA with a central mismatch relative to the RNA target.
Figure 4. An example of the impact of cooperative binding on repression of gene expression by duplex RNAs. In this example an anti-CAG repeat duplex RNA is introduced into patient-derived Huntington's disease cells. (A) The wild-type huntingtin (HTT) allele has 17 repeats, while the mutant allele has 69 repeats. 1–2 anti-CAG small RNAs can bind to the wild-type allele while as many as nine anti-CAG RNAs can bind to the mutant allele. (B) Allele selective inhibition by a small RNA with a central mismatch relative to the RNA target.CC BY-NC · PubMed Central
Figure 5. Single versus multiple binding of miRNAs and cooperativity. (A) Binding of a single miRNA to a target, no potential for cooperativity. Multiple miRNAs of the (B) same or (C) different miRNA families. (D) Bridging of AGO:miRNA complexes by TNRC6 scaffolding protein provides a structural basis for cooperativity.
Figure 5. Single versus multiple binding of miRNAs and cooperativity. (A) Binding of a single miRNA to a target, no potential for cooperativity. Multiple miRNAs of the (B) same or (C) different miRNA families. (D) Bridging of AGO:miRNA complexes by TNRC6 scaffolding protein provides a structural basis for cooperativity.CC BY-NC · PubMed Central
Figure 6. Interplay of miRNA and target concentration. miR-122 was prioritized for study because of (A) high expression in hepatocyte cells relative to most other miRNAs and (B) other cell types. (C) Model showing the correlation between miRNA concentration, target mRNA concentration, and potential for biologically significant inhibition of gene expression. CPM – counts per million. Data obtained from FANTOM5 database (77).
Figure 6. Interplay of miRNA and target concentration. miR-122 was prioritized for study because of (A) high expression in hepatocyte cells relative to most other miRNAs and (B) other cell types. (C) Model showing the correlation between miRNA concentration, target mRNA concentration, and potential for biologically significant inhibition of gene expression. CPM – counts per million. Data obtained from FANTOM5 database (77).CC BY-NC · PubMed Central
Figure 7. Anti-miRs, tools for investigating the function of miRNAs. When an anti-miR is present it has the potential to block the miRNA and prevent miRNA-mediated repression of the target RNA.
Figure 7. Anti-miRs, tools for investigating the function of miRNAs. When an anti-miR is present it has the potential to block the miRNA and prevent miRNA-mediated repression of the target RNA.CC BY-NC · PubMed Central
Figure 8. Challenges to identifying candidate miRNAs from CLIP data and predictions programs. (A, B) Show AGO2 eCLIP data (60) in HCT116 cells for the MYC 3′-UTR. miRNAs were predicted using (A) TargetScan or (B) miRANDA. (C) Let-7f, can example of a highly expressed miRNA that was not predicted by TargetScan but was predicted by miRANDA. Red labeled miRNAs significantly loaded on AGO2 over AGO2 KO cell line.
Figure 8. Challenges to identifying candidate miRNAs from CLIP data and predictions programs. (A, B) Show AGO2 eCLIP data (60) in HCT116 cells for the MYC 3′-UTR. miRNAs were predicted using (A) TargetScan or (B) miRANDA. (C) Let-7f, can example of a highly expressed miRNA that was not predicted by TargetScan but was predicted by miRANDA. Red labeled miRNAs significantly loaded on AGO2 over AGO2 KO cell line.CC BY-NC · PubMed Central
Figure 9. The miRNA literature. Publications identified by PubMed searches for the terms ‘miRNA’ and ’miRNA and cancer’, 2000–2020.
Figure 9. The miRNA literature. Publications identified by PubMed searches for the terms ‘miRNA’ and ’miRNA and cancer’, 2000–2020.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 199

Metadata

Authors
Kilikevicius, A., Meister, G., & Corey, D. R.
Affiliations
  • Department of Pharmacology and Biochemistry, UT Southwestern Medical Center, 6001 Forest Park Road, Dallas, TX, USA
  • University of Regensburg (DE)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Corey, David R
Venue
Nucleic Acids Research
Published
2021-12-30
Volume
50
Issue
2
Pages
617-634
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W4206028820
Cited by
194
References
120
Citations by year
2026: 27 · 2025: 57 · 2024: 56 · 2023: 35 · 2022: 19
FWCI
3.47
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (GM118103)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
Keywords
microRNA, RNA interference, gene expression regulation, miRNA-based therapy, miRNA-disease associations
MeSH terms
Clinical Studies as Topic, Antagomirs, Drug Development, Animals, Base Sequence, Drug Evaluation, Preclinical, Humans, Structure-Activity Relationship, Genetic Variation, Treatment Outcome, Base Pairing, Gene Silencing, RNA Interference, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.